Paroxetine/bupropion combination treatment for refractory depression

被引：27

作者：

Marshall, RD

Liebowitz, MR

机构：

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1996年 / 16卷 / 01期

关键词：

D O I：

10.1097/00004714-199602000-00016

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：80 / 81

页数：2

共 8 条

[1] THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES [J].

CREWE, HK ;

LENNARD, MS ;

TUCKER, GT ;

WOODS, FR ;

HADDOCK, RE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :262-265

[2]

DEWILDE J, 1993, ACTA PSYCHIAT SCAND, V87, P141

[3]

FERRIS RM, 1983, J CLIN PSYCHIAT, V44, P74

[4] BUPROPION AND SERTRALINE COMBINATION TREATMENT IN REFRACTORY DEPRESSION [J].

MARSHALL, RD ;

JOHANNET, CM ;

COLLINS, PY ;

SMITH, H ;

KAHN, DA ;

DOUGLAS, CJ .

JOURNAL OF PSYCHOPHARMACOLOGY, 1995, 9 (03) :284-286

[5]

NOVAC A, 1992, J CLIN PSYCHIAT, V53, P67

[6] DOWN REGULATION OF BETA-RECEPTORS BY BUPROPION AND ITS MAJOR METABOLITE IN MOUSE-BRAIN [J].

PERUMAL, AS ;

SMITH, TM ;

SUCKOW, RF ;

COOPER, TB .

NEUROPHARMACOLOGY, 1986, 25 (12) :1323-1326

[7] EFFECT OF PLASMA FROM PATIENTS CONTAINING BUPROPION AND ITS METABOLITES ON THE UPTAKE OF NOREPINEPHRINE [J].

PERUMAL, AS ;

SMITH, TM ;

SUCKOW, RF ;

COOPER, TB .

NEUROPHARMACOLOGY, 1986, 25 (02) :199-202

[8]

WEILBURG JB, 1991, ANN CLIN PSYCHIATRY, V3, P209

← 1 →